Results 31 to 40 of about 34,375 (153)
What's New? Low‐ and middle‐income countries have over 70% of the global cancer burden but 10% of the world's radiotherapy capacities. This population‐based multi‐country study explores the barriers to access experienced by cancer patients in sub‐Saharan Africa.
Eric Sven Kroeber +21 more
wiley +1 more source
L’annonce en cancérologie [PDF]
En cancérologie, le dispositif d’annonce marque une avancée positive dans la prise en charge des patients. Pour autant, aucun dispositif ne solutionnera par lui-même les difficultés qu’il y a à dire et à entendre la maladie. C’est ce contenu de l’annonce
Spire, Antoine, Poinsot, Rollon
core +1 more source
What's new? While the effectiveness of systemic anticancer therapy is well documented, it commonly causes severe toxicity. This study of the 467 systemic anticancer therapy agents currently approved globally for clinical and/or research purposes found that peripheral neurotoxicity is associated with 45% of classical chemotherapies, 21% of targeted ...
Cassie Higgins +3 more
wiley +1 more source
Réseaux régionaux en cancérologie, collaboration équipes adulte et pédiatrique
International audienceRegional cancer networks missions have been defined by successive “Plan Cancer” and are focused on coordination and the safety and quality of care.
Empereur, Fabienne +3 more
core +1 more source
Background Intravenous administration of $$^{177}$$ Lu-labeled radiopharmaceuticals (RPMs) such as PSMA and DOTATATE entails a risk of extravasation, potentially resulting in absorbed doses exceeding thresholds for deterministic tissue damage.
Olivia Lienhardt +7 more
doaj +1 more source
Abstract BackgroundWhile positioning errors during radiotherapy are increasingly well‐characterized and accounted for in the Planning Target Volume (PTV), little is known about the shape and volume changes of the breast in the course of radiotherapy. Yet they represent an unknown factor that may impact treatment effectiveness, highlighting the need to ...
Pierre Galmiche +5 more
wiley +1 more source
Abstract Introduction: VIPoma is an extremely rare functioning pancreatic neuroendocrine tumor. Therefore, data regarding treatment and outcome are very limited. Aim (s): This multicenter study aimed to analyze clinical characteristics, real‐world management, and outcomes of patients with VIPoma.
Detlef K. Bartsch +15 more
wiley +1 more source
Essais précoces en cancérologie, éthique et justice
National audienceC'est dans le cadre d'un programme de recherche sur l'égalité d'accès aux essais cliniques de cancérologie ("EgaliCan") que le symposium "Essais précoces en cancérologie : quelles définitions, quelle justice ?" s'est tenu au Collège de ...
Gateau, Valérie, Amiel, Philippe
core +1 more source
ABSTRACT Purpose Patient activation—encompassing knowledge, confidence, and skills in managing individual's health—is a cornerstone of person‐centered care. However, its significance among childhood, adolescent, and young adult cancer survivors (CAYACS) remains unexplored. This article examines the application of the 13‐item Patient Activation Measure (
Charlotte Demoor‐Goldschmidt +12 more
wiley +1 more source
ABSTRACT Metastatic Ewing sarcoma (MES) has a poor prognosis. This multicenter observational study provides real‐world data on treatment patterns of patients with MES in France. Treatment characteristics, outcomes such as time to next treatment (TTNT) and overall survival (OS), and prognostic factors of patients aged ≥ 12 years treated for a MES in 11 ...
Coline Ducrot +24 more
wiley +1 more source

